AC682

· Accutar Biotechnology Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC682, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer [Phase 1]